The US Food and Drug Administration (FDA) recognized the use of a qualified health claim related with the early peanut introduction and reduced risk of developing peanut allergy.
The claim, which manufacturers can use immediately, reads:
For most infants with severe eczema and/or egg allergy who are already eating solid foods, introducing foods containing ground peanuts between 4 and 10 months of age and continuing consumption may reduce the risk of developing peanut allergy by 5 years of age. FDA has determined, however, that the evidence supporting this claim is limited to one study.
Qualified health claims are supported by credible scientific evidence, but do not meet the more rigorous “significant scientific agreement” standard required for an authorized health claim.